Assembly Biosciences Inc (ASMB) — Long-term Investment Intensity

Latest as of June 2022: 8.3%

Assembly Biosciences Inc (ASMB) has a Long-term Investment Intensity of 8.3% as of June 2022. Long-term investments of $11.91 Million represent 8.3% of total assets of $143.45 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Assembly Biosciences Inc book value and equity for net asset value and shareholders' equity analysis.

LT Investment Intensity

8.3%
LT Investments / Total Assets

Long-term Investments

$11.91 Million
USD

Total Assets

$143.45 Million
USD

Country

USA
NASDAQ

Assembly Biosciences Inc Long-term Investment Intensity (2015–2021)

This chart shows how Assembly Biosciences Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2021. As of June 2022, the intensity stands at 8.3%, reflecting long-term investments of $11.91 Million against total assets of $143.45 Million USD. Also explore how large is Assembly Biosciences Inc's balance sheet for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Assembly Biosciences Inc (2015–2021)

The table below presents the year-by-year Long-term Investment Intensity for Assembly Biosciences Inc from 2015 to 2021, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Assembly Biosciences Inc.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2021 14.6% $27.97 Million $191.06 Million ▲ +12.7 pp
2017 2.0% $3.35 Million $169.30 Million ▼ -0.5 pp
2016 2.5% $2.44 Million $98.12 Million ▼ -15.0 pp
2015 17.5% $23.39 Million $133.74 Million
pp = percentage points